The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Randomized phase III study of high-dose methotrexate and whole brain radiotherapy with or without concomitant and adjuvant temozolomide in patients with newly diagnosed primary central nervous system lymphoma: JCOG1114C.
 
Kazuhiko Mishima
Speakers' Bureau - Chugai Pharma; Ono Pharmaceutical
Research Funding - Chugai Pharma (Inst); Eisai (Inst); Medical U and A, Inc (Inst); MSD (Inst); Nihon Medi-Physics (Inst); Ono Pharmaceutical (Inst); Otsuka (Inst); Teijin Pharma (Inst)
 
Ryo Nishikawa
Honoraria - Abbvie; Chugai Pharma; Eisai; Nihonkayaku
Consulting or Advisory Role - Daiichi Sankyo; Novocure; Ono Pharmaceutical
Research Funding - Chugai Pharma (Inst); Eisai (Inst); MSD (Inst)
Expert Testimony - Daiichi Sankyo; Novocure; Ono Pharmaceutical
 
Yoshitaka Narita
Honoraria - Abbvie; Canon Medical System; Chugai Pharma; Daiichi Sankyo; Eisai; Novocure; Otsuka; Takeda
Consulting or Advisory Role - Abbvie; Sumitomo Group
Research Funding - Abbvie (Inst); Bayer (Inst); Daiichi Sankyo (Inst); Eisai (Inst); Novocure (Inst); Ono Pharmaceutical (Inst); SBI Pharmaceuticals (Inst); Sumitomo Group (Inst); Taiho Pharmaceutical (Inst)
 
Junki Mizusawa
Honoraria - Chugai Pharma; Taiho Pharmaceutical
 
Minako Sumi
No Relationships to Disclose
 
Manabu Kinoshita
Speakers' Bureau - BrainLab; Daiichi Sankyo; Eisai; Integra LifeSciences; Novocure; Varian Medical Systems
Travel, Accommodations, Expenses - Integra LifeSciences
 
Motoo Nagane
Honoraria - Abbvie; Chugai Pharma; Daiichi Sankyo/UCB Japan; Eisai; Infront; MSD; Nippon Kayaku; Novocure; Springer
Consulting or Advisory Role - Abbvie; Bristol-Myers Squibb; Daiichi Sankyo; Dainippon Sumitomo Pharma; Ono Pharmaceutical; RIEMSER
Research Funding - Astellas Pharma (Inst); Chugai Pharma; Daiichi Sankyo; Daiichi Sankyo (Inst); Eisai; HOYA Techonosurgical (Inst); MSD; Nihonkayaku (Inst); Ono Pharmaceutical; Otsuka (Inst); Pfizer (Inst); Saney Seiko (Inst); Sanofi (Inst); Sanofi (Inst); Shionogi (Inst); Stryker (Inst); Tsumura & Co. (Inst)
Travel, Accommodations, Expenses - Abbvie; Bristol-Myers Squibb; Chugai Pharma; Daiichi Sankyo; Eisai; MSD K.K; Nippon Kayaku; Ono Pharmaceutical
 
Yoshiki Arakawa
Speakers' Bureau - Abbvie; Brainlab; Carl Zeiss Meditec; Chugai Pharma; CSL Behring; CSL Behring; Daiichi Sankyo; Eisai; Integra LifeSciences; Meiji Seika Kaisha; Merck; Nippon Kayaku; Novocure; Otsuka; UCB
Research Funding - Astellas Amgen BioPharama; Brainlab; Carl Zeiss Meditec; Chugai Pharma; CSL Behring; Daiichi Sankyo; Eisai; Meiji Seika Kaisha; Merck; Mitsubishi Tanabe Pharma; Nihon Medi-Physics; Pfizer; Philips Electronics; Sanofi; Siemens; Stryker; Takeda
 
Koji Yoshimoto
No Relationships to Disclose
 
Ichiyo Shibahara
No Relationships to Disclose
 
Naoki Shinojima
No Relationships to Disclose
 
Kenichiro Asano
No Relationships to Disclose
 
Takao Tsurubuchi
No Relationships to Disclose
 
Hikaru Sasaki
Speakers' Bureau - Chugai Pharma; Eisai; Nippon Kayaku
Research Funding - Ono Pharmaceutical
Travel, Accommodations, Expenses - Chugai Pharma; Leica Biosystems
 
Akio Asai
No Relationships to Disclose
 
Takashi Sasayama
No Relationships to Disclose
 
Yasutomo Momii
No Relationships to Disclose
 
Atsushi Sasaki
No Relationships to Disclose
 
Hiroshi Katayama
No Relationships to Disclose
 
Haruhiko Fukuda
Honoraria - Chugai Pharma; Taiho Pharmaceutical